Navigation Links
Warner Chilcott Successfully Completes Refinancing of Senior Secured Credit Facilities and Updates Full Year 2011 Financial Guidance
Date:3/17/2011

ceptance of our existing products; our ability to realize the anticipated opportunities from the PGP Acquisition; and the other risks identified in our periodic filings including our Annual Report on Form 10-K for the year ended December 31, 2010, and from time-to-time in our other investor communications.

We caution you that the foregoing list of important factors is not exclusive. In addition, in light of these risks and uncertainties, the matters referred to in our forward-looking statements may not occur. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as may be required by law. WARNER CHILCOTT PUBLIC LIMITED COMPANY2011 Full Year Financial Guidance(In millions of U.S. dollars, except per share amounts)Prior Guidance
February 2011 Current Guidance
March 2011Total Revenue (1)$2,700 to $2,800$2,700 to $2,800Gross Margin as a % of Total Revenue (2)88% to 89%88% to 89%Total SG&A Expense (3)$900 to $950$900 to $950Total R&D Expense (4)$150 to $170$150 to $170Total Income Tax Provision (5)10%-11% of EBTA10%-11% of EBTAGAAP Net Income (6)$270 to $296$255 to $281Cash Net Income ("CNI") (7)$883 to $909$922 to $948CNI per share (6) (7)$3.45 to $3.55$3.60 to $3.70(1)

The 2011 guidance assumes (i) that generic equivalents of our DORYX 150 mg, ASACOL 400 mg and ESTRACE CREAM products will not be approved and enter the U.S. market during 2011; (ii) that a generic equivalent of FEMCON FE will be approved and enter the market as early as March 2011; (iii) the expected impact of the loss of exclusivity for ACTONEL in Western European markets and (iv) the growth of our promoted products as compared to the prior year. In addition our 2011 guidance accounts for revenues expected from the launch of ATELVIA and LO LOESTRIN FE in January 2011. The guidance does not ac
'/>"/>

SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive
2. Warner Chilcott Announces 2011 Financial Guidance Conference Call
3. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
4. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
7. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
8. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
9. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
10. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period
11. EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the device," Nobel laureate Herbert Kroemer famously observed, ... at the junctures where layers of different materials ... interfaces between layers of metal oxides are becoming ... as spintronics, high-temperature superconductors, ferroelectrics and multiferroics. Realizing ...
(Date:1/15/2014)... 15, 2014 Look inside the new ... for the lab, from fluid handling to instruments to ... ship when you order. , Preferred Solutions features ... from the L/S® model for precise flow control and ...
(Date:1/15/2014)... 2014 This webinar will focus on ... safety assessment in biosimilars. , Regulatory frameworks are evolving ... development, however the complex nature of biopharmaceuticals makes the ... efficacy extremely challenging. Based on the specific aspects of ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 The ... cause a major disease. One of these latent viruses is ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... the theory, a study found that RA patients have high ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... LYNBROOK, N.Y., June 29 BioSpecifics Technologies Corp. (Nasdaq: ... collagenase-based products, announced today that it was added to the ... of the U.S. markets on June 29, 2009. The Russell ... to be a comprehensive representation of the investable U.S. equity ...
... Kendle (Nasdaq: KNDL ), a leading, ... of Jarrod Pontius to the position of Chief Legal ... leadership for all legal services, corporate governance and general ... based in Kendle,s global headquarters in Cincinnati and will ...
... , , , BATESVILLE, Ind., June ... the sale of Hill-Rom,s patents and intellectual property relating to ... KCI ). Hill-Rom,s NPWT portfolio included U.S. ... components, protocols, and related therapies. The transaction is effective immediately. ...
Cached Biology Technology:BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes 2Kendle Names Jarrod Pontius Chief Legal Officer 2Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property 2Hill-Rom Announces Sale of Negative Pressure Wound Therapy Intellectual Property 3
(Date:4/17/2014)... Texas Medical Branch at Galveston are the first ... for cervical cancer should begin colorectal cancer screening ... researchers, finding a high incidence of secondary colorectal ... offer new recommendations that the younger women in ... years after their initial cervical cancer diagnosis instead ...
(Date:4/17/2014)... from Charles Darwin, whose ideas in turn were ... 19th century, a period when landowners vigorously pursued ... Darwin that we inherit the ideas that domestication ... and total human control over breeding and animal ... setting has been applied too broadly in time ...
(Date:4/16/2014)... cannot lift your upper eyelid. You walk through life with your ... are rolled down in the eye socket. Obviously, such a condition ... head. In order to correct this condition, one would need to ... April 16 print issue of the journal Neuron , University ...
Breaking Biology News(10 mins):Radiation therapy for cervical cancer increases risk for colorectal cancer 2The story of animal domestication retold 2The story of animal domestication retold 3The story of animal domestication retold 4Researchers track down cause of eye mobility disorder 2
... City once topped lists of places with the worst air ... improved the situation, tiny particles called aerosols still clog the ... other institutions have sorted through the pall that hangs over ... haze and chart daily patterns of changes to the mix. ...
... SEPTEMBER 2, 2008 Varying the rate of crop production ... as farmers have long observed differences in crop yield ... of spatial yield information from combines equipped with yield ... So, optimizing inputs to match yield potential ...
... visitor might blink twice at the sight of a ... the northern edge of Arizona State University (ASU), is ... canals and dams combining flood control, water delivery, recreational ... and economics in the area. What are ...
Cached Biology News:Smoke smudges Mexico City's air, chemists identify sources 2Smoke smudges Mexico City's air, chemists identify sources 3A little nitrogen can go a long way 2A little nitrogen can go a long way 3Evolving designer ecosystem sheds light on unintended consequences 2Evolving designer ecosystem sheds light on unintended consequences 3Evolving designer ecosystem sheds light on unintended consequences 4
... For use in hybridization incubators ... and GL 45 size PP plug-seal ... seal. Available in three lengths to ... plug-seal caps and O-rings available separately. ...
... Rapid, efficient extraction of DNA from agarose gels ... of DNA fragments of 150 bp to > 12,000 ... GelMelt solution to dissolve the gel slice, followed by ... a spin column format. After a wash step, the ...
Fujifilm BAS-1800II provides the ideal configuration for a low-cost imager that requires only a small amount of space in the laboratory. The small imager for accurate high-throughput screening...
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
Biology Products: